Published in Mediators Inflamm on September 30, 2015
Cellular Barriers after Extravasation: Leukocyte Interactions with Polarized Epithelia in the Inflamed Tissue. Mediators Inflamm (2016) 0.77
Plasmodium berghei NK65 in Combination with IFN-γ Induces Endothelial Glucocorticoid Resistance via Sustained Activation of p38 and JNK. Front Immunol (2017) 0.75
Artesunate versus quinine for treatment of severe falciparum malaria: a randomised trial. Lancet (2005) 12.98
Structural and functional features of central nervous system lymphatic vessels. Nature (2015) 8.73
Human cerebral malaria. A quantitative ultrastructural analysis of parasitized erythrocyte sequestration. Am J Pathol (1985) 7.14
Phenotypic heterogeneity of the endothelium: I. Structure, function, and mechanisms. Circ Res (2007) 5.60
Heme oxygenase-1 and carbon monoxide suppress the pathogenesis of experimental cerebral malaria. Nat Med (2007) 4.22
Statins selectively inhibit leukocyte function antigen-1 by binding to a novel regulatory integrin site. Nat Med (2001) 3.69
Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation. Nat Immunol (2008) 3.15
Impaired nitric oxide bioavailability and L-arginine reversible endothelial dysfunction in adults with falciparum malaria. J Exp Med (2007) 3.13
Severe malaria is associated with parasite binding to endothelial protein C receptor. Nature (2013) 2.86
Stabilized imaging of immune surveillance in the mouse lung. Nat Methods (2010) 2.66
Use of peroxisome proliferator-activated receptor gamma agonists as adjunctive treatment for Plasmodium falciparum malaria: a randomized, double-blind, placebo-controlled trial. Clin Infect Dis (2009) 2.66
The anti-malarial artesunate is also active against cancer. Int J Oncol (2001) 2.56
The role of heparan sulphate in inflammation. Nat Rev Immunol (2006) 2.51
Evidence of blood-brain barrier dysfunction in human cerebral malaria. Neuropathol Appl Neurobiol (1999) 2.29
Heme oxygenase-1 affords protection against noncerebral forms of severe malaria. Proc Natl Acad Sci U S A (2009) 2.11
Decreased endothelial nitric oxide bioavailability, impaired microvascular function, and increased tissue oxygen consumption in children with falciparum malaria. J Infect Dis (2014) 2.10
Leukocyte extravasation and vascular permeability are each controlled in vivo by different tyrosine residues of VE-cadherin. Nat Immunol (2014) 2.10
Angiopoietin-2 levels are associated with retinopathy and predict mortality in Malawian children with cerebral malaria: a retrospective case-control study*. Crit Care Med (2012) 1.97
Pathogenesis of cerebral malaria: recent experimental data and possible applications for humans. Clin Microbiol Rev (2001) 1.91
Vascular clogging, mononuclear cell margination, and enhanced vascular permeability in the pathogenesis of human cerebral malaria. Am J Trop Med Hyg (1994) 1.91
Cerebral malaria: why experimental murine models are required to understand the pathogenesis of disease. Parasitology (2009) 1.87
The neuropathology of fatal cerebral malaria in malawian children. Am J Pathol (2011) 1.79
The role of animal models for research on severe malaria. PLoS Pathog (2012) 1.76
Release of hepatic Plasmodium yoelii merozoites into the pulmonary microvasculature. PLoS Pathog (2007) 1.67
Perivascular spaces and the two steps to neuroinflammation. J Neuropathol Exp Neurol (2008) 1.52
Nitric oxide synthase in innate and adaptive immunity: an update. Trends Immunol (2015) 1.46
Role of ICAM-1 (CD54) in the development of murine cerebral malaria. Microbes Infect (1999) 1.37
Brain swelling and death in children with cerebral malaria. N Engl J Med (2015) 1.37
Role of polymorphonuclear neutrophil leukocytes and their integrin CD11a (LFA-1) in the pathogenesis of severe murine malaria. Infect Immun (1994) 1.35
Neuroimmunological blood brain barrier opening in experimental cerebral malaria. PLoS Pathog (2012) 1.35
Resolution of inflammation in murine autoimmune arthritis is disrupted by cyclooxygenase-2 inhibition and restored by prostaglandin E2-mediated lipoxin A4 production. J Immunol (2010) 1.31
Control of pathogenic CD8+ T cell migration to the brain by IFN-gamma during experimental cerebral malaria. Parasite Immunol (2008) 1.30
Respiratory manifestations of malaria. Chest (2012) 1.29
VEGF promotes malaria-associated acute lung injury in mice. PLoS Pathog (2010) 1.28
In vivo imaging of malaria parasites in the murine liver. Nat Protoc (2007) 1.23
Endothelial cells from diverse tissues exhibit differences in growth and morphology. Microvasc Res (1998) 1.22
Simultaneous host and parasite expression profiling identifies tissue-specific transcriptional programs associated with susceptibility or resistance to experimental cerebral malaria. BMC Genomics (2006) 1.20
Acute lung injury and acute respiratory distress syndrome in malaria. J Vector Borne Dis (2008) 1.16
Nitric oxide protection against murine cerebral malaria is associated with improved cerebral microcirculatory physiology. J Infect Dis (2011) 1.16
Plasmodium falciparum adhesion on human brain microvascular endothelial cells involves transmigration-like cup formation and induces opening of intercellular junctions. PLoS Pathog (2010) 1.16
Lung injury in uncomplicated and severe falciparum malaria: a longitudinal study in papua, Indonesia. J Infect Dis (2005) 1.14
The anti-malaria drug artesunate inhibits replication of cytomegalovirus in vitro and in vivo. Antiviral Res (2005) 1.14
Immunopathology and dexamethasone therapy in a new model for malaria-associated acute respiratory distress syndrome. Am J Respir Crit Care Med (2010) 1.14
Acute renal failure associated with malaria. J Ayub Med Coll Abbottabad (2007) 1.14
Statins decrease neuroinflammation and prevent cognitive impairment after cerebral malaria. PLoS Pathog (2012) 1.11
A pilot study of N-acetylcysteine as adjunctive therapy for severe malaria. QJM (2002) 1.11
The systemic pathology of cerebral malaria in African children. Front Cell Infect Microbiol (2014) 1.10
Immune privilege of the CNS is not the consequence of limited antigen sampling. Sci Rep (2014) 1.09
Src-family kinase dependent disruption of endothelial barrier function by Plasmodium falciparum merozoite proteins. Blood (2007) 1.07
Inhaled nitric oxide for the adjunctive therapy of severe malaria: protocol for a randomized controlled trial. Trials (2011) 1.06
Pathogenesis of cerebral malaria--inflammation and cytoadherence. Front Cell Infect Microbiol (2014) 1.06
Hemozoin induces lung inflammation and correlates with malaria-associated acute respiratory distress syndrome. Am J Respir Cell Mol Biol (2013) 1.06
Murine cerebral malaria: how far from human cerebral malaria? Trends Parasitol (2010) 1.05
Altered phenotype and gene transcription in endothelial cells, induced by Plasmodium falciparum-infected red blood cells: pathogenic or protective? Int J Parasitol (2007) 1.05
Exogenous nitric oxide decreases brain vascular inflammation, leakage and venular resistance during Plasmodium berghei ANKA infection in mice. J Neuroinflammation (2011) 1.04
Pathogenic role of P-selectin in experimental cerebral malaria: importance of the endothelial compartment. Am J Pathol (2004) 1.03
Sulforaphane preconditioning of the Nrf2/HO-1 defense pathway protects the cerebral vasculature against blood-brain barrier disruption and neurological deficits in stroke. Free Radic Biol Med (2013) 1.03
Delayed mortality and attenuated thrombocytopenia associated with severe malaria in urokinase- and urokinase receptor-deficient mice. Infect Immun (2000) 1.03
A randomized pilot study of L-arginine infusion in severe falciparum malaria: preliminary safety, efficacy and pharmacokinetics. PLoS One (2013) 1.02
S1P is associated with protection in human and experimental cerebral malaria. Mol Med (2011) 1.02
Cytokines and adhesion molecules expression in the brain in human cerebral malaria. Int J Environ Res Public Health (2005) 1.00
Plasma levels of angiopoietin-1 and -2 predict cerebral malaria outcome in Central India. Malar J (2011) 0.99
Levamisole inhibits sequestration of infected red blood cells in patients with falciparum malaria. J Infect Dis (2007) 0.99
Endothelial activation and dysregulation in malaria: a potential target for novel therapeutics. Curr Opin Hematol (2011) 0.99
Real-time imaging reveals the dynamics of leukocyte behaviour during experimental cerebral malaria pathogenesis. PLoS Pathog (2014) 0.98
Pulmonary pathology in pediatric cerebral malaria. Hum Pathol (2013) 0.97
Experimental cerebral malaria pathogenesis--hemodynamics at the blood brain barrier. PLoS Pathog (2014) 0.97
Effects of artesunate, dihydroartemisinin, and an artesunate-dihydroartemisinin combination against Toxoplasma gondii. Am J Trop Med Hyg (2000) 0.96
Investigating the Pathogenesis of Severe Malaria: A Multidisciplinary and Cross-Geographical Approach. Am J Trop Med Hyg (2015) 0.96
Atorvastatin prevents Plasmodium falciparum cytoadherence and endothelial damage. Malar J (2011) 0.96
Nuclear factor kappa B modulates apoptosis in the brain endothelial cells and intravascular leukocytes of fatal cerebral malaria. Malar J (2013) 0.95
Intercellular adhesion molecule 1 is important for the development of severe experimental malaria but is not required for leukocyte adhesion in the brain. J Investig Med (2003) 0.93
Association between early childhood exposure to malaria and children's pre-school development: evidence from the Zambia early childhood development project. Malar J (2013) 0.92
Lipoxins: regulators of resolution. Curr Opin Pharmacol (2010) 0.92
Cell-based therapies for the acute respiratory distress syndrome. Curr Opin Crit Care (2014) 0.90
Amplification of P. falciparum Cytoadherence through induction of a pro-adhesive state in host endothelium. PLoS One (2011) 0.89
Activated Brain Endothelial Cells Cross-Present Malaria Antigen. PLoS Pathog (2015) 0.89
Evidence that 5-lipoxygenase and acetylated cyclooxygenase 2-derived eicosanoids regulate leukocyte-endothelial adherence in response to aspirin. Br J Pharmacol (2003) 0.88
Andrographolide inhibits TNFα-induced ICAM-1 expression via suppression of NADPH oxidase activation and induction of HO-1 and GCLM expression through the PI3K/Akt/Nrf2 and PI3K/Akt/AP-1 pathways in human endothelial cells. Biochem Pharmacol (2014) 0.87
Curcumin ameliorates the permeability of the blood-brain barrier during hypoxia by upregulating heme oxygenase-1 expression in brain microvascular endothelial cells. J Mol Neurosci (2013) 0.86
Predictive criteria to study the pathogenesis of malaria-associated ALI/ARDS in mice. Mediators Inflamm (2014) 0.86
Protective cross talk between activated protein C and TNF signaling in vascular endothelial cells: implication of EPCR, noncanonical NF-κB, and ERK1/2 MAP kinases. Am J Physiol Cell Physiol (2011) 0.85
Natural haemozoin modulates matrix metalloproteinases and induces morphological changes in human microvascular endothelium. Cell Microbiol (2011) 0.85
The antimalarial artemisinin synergizes with antibiotics to protect against lethal live Escherichia coli challenge by decreasing proinflammatory cytokine release. Antimicrob Agents Chemother (2006) 0.84
Improvement of the efficacy of dihydroartemisinin with atorvastatin in an experimental cerebral malaria murine model. Malar J (2013) 0.84
Endothelial cell activation in muscle biopsy samples is related to clinical severity in human cerebral malaria. J Infect Dis (1999) 0.84
Severe sepsis due to severe falciparum malaria and leptospirosis co-infection treated with activated protein C. Malar J (2007) 0.84
Lipoxin A₄ and 15-epi-lipoxin A₄ protect against experimental cerebral malaria by inhibiting IL-12/IFN-γ in the brain. PLoS One (2013) 0.84
Toxoplasma gondii: the severity of toxoplasmic encephalitis in C57BL/6 mice is associated with increased ALCAM and VCAM-1 expression in the central nervous system and higher blood-brain barrier permeability. Exp Parasitol (2010) 0.83
Immunomodulation in Plasmodium falciparum malaria: experiments in nature and their conflicting implications for potential therapeutic agents. Expert Rev Anti Infect Ther (2012) 0.83
Mild Plasmodium falciparum malaria following an episode of severe malaria is associated with induction of the interferon pathway in Malawian children. Infect Immun (2012) 0.83
Effect of the use of low and high potency statins and sepsis outcomes. Intensive Care Med (2014) 0.83
Extracorporeal membrane oxygenation for refractory acute respiratory distress syndrome in severe malaria. Malar J (2013) 0.83
PPARγ agonists improve survival and neurocognitive outcomes in experimental cerebral malaria and induce neuroprotective pathways in human malaria. PLoS Pathog (2014) 0.82
Early and late acute lung injury and their association with distal organ damage in murine malaria. Respir Physiol Neurobiol (2013) 0.82
Mesenchymal stromal cell therapy attenuated lung and kidney injury but not brain damage in experimental cerebral malaria. Stem Cell Res Ther (2015) 0.82
Imaging Plasmodium immunobiology in the liver, brain, and lung. Parasitol Int (2013) 0.81
Ultrastructure of the lung in a murine model of malaria-associated acute lung injury/acute respiratory distress syndrome. Malar J (2014) 0.81
Neuregulin-1 attenuates mortality associated with experimental cerebral malaria. J Neuroinflammation (2014) 0.81